- Home
- APGE vs TTMI Comparison
APGE vs TTMI Comparison
Compare APGE & TTMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- TTMI
- Stock Information
- Founded
- APGE 2022
- TTMI 1978
- Country
- APGE United States
- TTMI United States
- Employees
- APGE N/A
- TTMI N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- TTMI Electrical Products
- Sector
- APGE Health Care
- TTMI Technology
- Exchange
- APGE Nasdaq
- TTMI Nasdaq
- Market Cap
- APGE 3.0B
- TTMI 2.5B
- IPO Year
- APGE 2023
- TTMI 2000
- Fundamental
- Price
- APGE $37.06
- TTMI $25.54
- Analyst Decision
- APGE Strong Buy
- TTMI Strong Buy
- Analyst Count
- APGE 5
- TTMI 4
- Target Price
- APGE $83.50
- TTMI $26.31
- AVG Volume (30 Days)
- APGE 488.2K
- TTMI 561.0K
- Earning Date
- APGE 03-04-2025
- TTMI 02-05-2025
- Dividend Yield
- APGE N/A
- TTMI N/A
- EPS Growth
- APGE N/A
- TTMI N/A
- EPS
- APGE N/A
- TTMI 0.66
- Revenue
- APGE N/A
- TTMI $2,360,827,000.00
- Revenue This Year
- APGE N/A
- TTMI $10.68
- Revenue Next Year
- APGE N/A
- TTMI $5.34
- P/E Ratio
- APGE N/A
- TTMI $38.64
- Revenue Growth
- APGE N/A
- TTMI 3.51
- 52 Week Low
- APGE $31.75
- TTMI $13.43
- 52 Week High
- APGE $72.29
- TTMI $28.00
- Technical
- Relative Strength Index (RSI)
- APGE 32.29
- TTMI 57.70
- Support Level
- APGE $36.48
- TTMI $24.18
- Resistance Level
- APGE $42.98
- TTMI $26.42
- Average True Range (ATR)
- APGE 2.92
- TTMI 0.70
- MACD
- APGE -0.99
- TTMI 0.02
- Stochastic Oscillator
- APGE 4.12
- TTMI 60.71
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About TTMI TTM Technologies Inc.
TTM Technologies Inc manufactures technology solutions, including mission systems, radio frequency (RF) components/RF microwave/microelectronic assemblies, quick-turn and technologically printed circuit boards (PCB). The company is based in the United States and derives roughly half of its revenue domestically. The company organizes itself into two segments: printed circuit boards and RF&S Components. The printed circuit boards segment, which contributes the majority of revenue, offers a range of printed circuit boards as well as layout design and simulation, and testing services. TTM Technologies' products are used in manufacturing, networking, telecommunications, computing, aerospace, and medical fields.